Rosetta Biosoftware and Iconix Pharmaceuticals Establish Interoperability for Gene Expression Data Analysis

Strategic Insights -

Rosetta Biosoftware and Iconix Pharmaceuticals, Inc. have announced a collaboration to establish interoperability between Rosetta Biosoftware's Resolver system and Iconix Pharmaceutical's DrugMatrix Informatics system. This partnership will enable researchers to analyze and manage DrugMatrix data, their own data, and data from other sources using the Rosetta Resolver system. The Rosetta Resolver system is a high-capacity data storage, retrieval, and analysis solution for gene expression data, designed to meet the scientific and business requirements of a global gene expression research effort.

Key Takeaways:

  • The partnership between Rosetta Biosoftware and Iconix Pharmaceuticals aims to provide researchers with a comprehensive gene expression data analysis solution.
  • The Rosetta Resolver system will enable users to analyze and manage DrugMatrix data, their own data, and data from other sources.
  • The collaboration will provide users with a scalable and easy-to-use analysis platform for gene expression data.
  • The Rosetta Resolver system has been licensed by many top pharmaceutical companies, including Aventis Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline, and Merck & Co., Inc.
  • The system is also used by academic institutions such as the Harvard University Center for Genomics Research.
  • Iconix Pharmaceuticals' DrugMatrix Informatics system is a reference chemogenomics database of drugs, standard toxicants, and biochemical standards.
  • Rosetta Biosoftware's Resolver system is a versatile and robust enterprise-wide gene expression data analysis system.
  • The partnership confirms Rosetta Biosoftware's commitment to future product enhancements enabling toxicogenomics research.

Statistics:

  • 1998: Iconix Pharmaceuticals was founded.
  • 2005: Rosetta Biosoftware and Iconix Pharmaceuticals announced their collaboration.
  • 6: Number of top pharmaceutical companies that have licensed the Rosetta Resolver system (Aventis Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline, and Merck & Co., Inc.).
  • 1: Number of academic institution that has used the Rosetta Resolver system (Harvard University Center for Genomics Research).

Sources:

  • Rosetta Biosoftware and Iconix Pharmaceuticals' press release, dated June 20, 2005.
  • Iconix Pharmaceuticals' website: www.iconixpharm.com.
  • Rosetta Biosoftware's website: www.rosettabio.com.
  • Merck & Co., Inc.'s Form 10-K for the year ended Dec. 31, 2004.